Type 2 & other diabetes

The relationship of inflammatory markers Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with HbA1c in Turkish diabetic patients

Diabetes Res Clin PractPublished Observational study

Authors' conclusion

In light of our findings, we propose a greater emphasis on routinely measuring inflammatory markers, such as NLR, in order to evaluate the glycemic control in patients with type 2 diabetes. We suggest that inflammatory marker-based approaches may be useful to monitor disease progression and maximize treatment outcomes in type 2 diabetes.

Study context

Population
Participants grouped by HbA1c, Ankara Bilkent Training and Research Hospital Clinical Biochemistry Department, December 2023
Participants
136 participants
Exposure
NLR and PLR across HbA1c-defined groups: DM vs Pre-DM vs control
Outcome
Relationship between HbA1c levels and inflammatory parameters NLR and PLR
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

NLR
  • Between DM and Control: P = 0.025
  • Between DM and Pre-DM: P = 0.034

Observational data: associations, not effects.

Further findings

Platelet and PLR levels were not statistically significant in group comparisons

Original publication

The relationship of inflammatory markers NLR and PLR with HbA1c in Turkish diabetic patients. Diabetes Res Clin Pract. Published 29 April 2025. doi:10.1016/j.diabres.2025.112213

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.